iifl-logo-icon 1

Bliss GVS Pharma Ltd Share Price

124.61
(-5.40%)
Oct 22, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open130.8
  • Day's High132.9
  • 52 Wk High149.6
  • Prev. Close131.73
  • Day's Low123
  • 52 Wk Low 77.35
  • Turnover (lac)1,328.82
  • P/E13.46
  • Face Value1
  • Book Value95.71
  • EPS9.27
  • Mkt. Cap (Cr.)1,312.17
  • Div. Yield0.4
View All Historical Data
No Records Found

Bliss GVS Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

130.8

Prev. Close

131.73

Turnover(Lac.)

1,328.82

Day's High

132.9

Day's Low

123

52 Week's High

149.6

52 Week's Low

77.35

Book Value

95.71

Face Value

1

Mkt Cap (₹ Cr.)

1,312.17

P/E

13.46

EPS

9.27

Divi. Yield

0.4

Bliss GVS Pharma Ltd Corporate Action

2 May 2024

12:00 AM

BookCloser

arrow

17 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

2 May 2024

12:00 AM

AGM

Announcement Date: 02 May, 2024

arrow

2 May 2024

12:00 AM

Dividend

Dividend Amount: 0.5

arrow

Bliss GVS Pharma Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bliss GVS Pharma Ltd SHAREHOLDING SNAPSHOT

23 Oct, 2024|09:10 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 34.90%

Foreign: 0.00%

Indian: 34.90%

Non-Promoter- 19.82%

Institutions: 19.82%

Non-Institutions: 45.27%

Custodian: 0.00%

Share Price

Bliss GVS Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

10.51

10.42

10.37

10.31

Preference Capital

0

0

0

0

Reserves

977.94

926.58

841.06

745.33

Net Worth

988.45

937

851.43

755.64

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

636.35

465.51

441.95

426.59

yoy growth (%)

36.7

5.33

3.6

43.2

Raw materials

-343.94

-253.3

-236.72

-225.14

As % of sales

54.04

54.41

53.56

52.77

Employee costs

-65.05

-58.6

-44.02

-33.84

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

123.65

91.18

121.71

120.01

Depreciation

-13.84

-13.76

-8.83

-5.74

Tax paid

-33.73

-23.68

-29.37

-45.57

Working capital

74.06

16.34

44.64

-0.64

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

36.7

5.33

3.6

43.2

Op profit growth

19.39

-8.69

7.58

5.23

EBIT growth

34.17

-24.46

2.52

31.32

Net profit growth

37.27

-26.89

24.04

30.55

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

770.24

751.59

747.45

577.21

689.31

Excise Duty

0

0

0

0

0

Net Sales

770.24

751.59

747.45

577.21

689.31

Other Operating Income

0

0

0

0

0

Other Income

28.74

17.79

31.49

20.22

39.19

Bliss GVS Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,887.55

162.644,52,670.53237.820.724,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,817.95

93.021,54,5124300.512,063507.93

Cipla Ltd

CIPLA

1,510.35

30.731,22,039.521,055.940.863,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,339.65

75.141,12,925.714690.842,394201.77

Dr Reddys Laboratories Ltd

DRREDDY

6,662.4

26.981,11,144.221,417.20.65,823.91,458.55

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Bliss GVS Pharma Ltd

Management

Register Office

Registrar Office

Whole-time Director

Vibha G Sharma

Whole-time Director

Shruti Vishal Rao

Chairman & Independent Directo

Subramanian R Vaidya

Non-Exec. & Independent Dir.

Santosh Parab

Company Sec. & Compli. Officer

Aditi Bhatt

Non-Exec. & Independent Dir.

Shilpa Bhatia

Managing Director

Gagan Harsh Sharmma

Independent Director

Nandkumar Kashinath Chodankar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries fastest-growing businesses. The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries. It has a strong foothold in Sub Saharan Africa. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its own manufacturing facility at Palghar which is WHO GMP approved. The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards.The company has a dedicated the R&D Centre for development of Suppositories, Semi Solids and Oral Solids with an experienced Team of over 50 Scientists for formulation development and analytical method development and certified by the Department of Scientific & Industrial Research (DSIR), Government of India.The company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma
Read More

Company FAQs

What is the Bliss GVS Pharma Ltd share price today?

The Bliss GVS Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹124.61 today.

What is the Market Cap of Bliss GVS Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bliss GVS Pharma Ltd is ₹1312.17 Cr. as of 22 Oct ‘24

What is the PE and PB ratio of Bliss GVS Pharma Ltd?

The PE and PB ratios of Bliss GVS Pharma Ltd is 13.46 and 1.33 as of 22 Oct ‘24

What is the 52 Week High and Low of Bliss GVS Pharma Ltd?

The 52-week high/low is the highest and lowest price at which a Bliss GVS Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bliss GVS Pharma Ltd is ₹77.35 and ₹149.6 as of 22 Oct ‘24

What is the CAGR of Bliss GVS Pharma Ltd?

Bliss GVS Pharma Ltd's CAGR for 5 Years at -1.62%, 3 Years at 5.37%, 1 Year at 51.78%, 6 Month at 7.75%, 3 Month at 14.34% and 1 Month at -8.33%.

What is the shareholding pattern of Bliss GVS Pharma Ltd?

The shareholding pattern of Bliss GVS Pharma Ltd is as follows:
Promoters - 34.90 %
Institutions - 19.83 %
Public - 45.27 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp